文献
(401~500)
401. Mullens W, Kepa J, De Vusser P, et al. Importance of adjunctive heart failure optimization immediately after implantation to improve
       longterm outcomes with cardiac resynchronization therapy. Am J Cardiol 2011; 108: 409-415. PMID: 21550578
402. Varma N, Epstein AE, Irimpen A, et al. TRUST Investigators. Efficacy and safety of automatic remote monitoring for implantable
       cardioverter- defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation 2010; 122: 325-
       332. PMID: 20625110
403. Watanabe E, Kasai A, Fujii E, et al. Reliability of implantable cardioverter defibrillator home monitoring in forecasting the need for regular
       office visits, and patient perspective. Japanese HOME-ICD study. Circ J 2013; 77: 2704-2711. PMID: 23903000
404. Guédon-Moreau L, Lacroix D, Sadoul N, et al. ECOST trial Investigators. A randomized study of remote follow-up of implantable
       cardioverter defibrillators: safety and efficacy report of the ECOST trial. Eur Heart J 2013; 34: 605-614. PMID: 23242192
405. Parthiban N, Esterman A, Mahajan R, et al. Remote Monitoring of Implantable Cardioverter-Defibrillators: A Systematic Review and
       Meta-Analysis of Clinical Outcomes. J Am Coll Cardiol 2015; 65: 2591-2600. PMID: 25983009
406. Slotwiner D, Varma N, Akar JG, et al. HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular
       implantable electronic devices. Heart Rhythm 2015; 12: e69-e100. PMID: 25981148
407. Landolina M, Perego GB, Lunati M, et al. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients
       with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO)
       study. Circulation 2012; 125: 2985-2992. PMID: 22626743
408. Crossley GH, Boyle A, Vitense H, et al. CONNECT Investigators. The CONNECT (Clinical Evaluation of Remote Notification to Reduce
       Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol 2011;
       57: 1181-1189. PMID: 21255955
409. Saxon LA, Hayes DL, Gilliam FR, et al. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up:
       the ALTITUDE survival study. Circulation 2010; 122: 2359-2367. PMID: 21098452
410. Hindricks G, Taborsky M, Glikson M, et al. IN-TIME study group. Implant-based multiparameter telemonitoring of patients with heart
       failure (IN-TIME): a randomised controlled trial. Lancet 2014; 384: 583-590. PMID: 25131977
411. Klersy C, Boriani G, De Silvestri A, et al. Health Economics Committee of the European Heart Rhythm Association. Effect of
       telemonitoring of cardiac implantable electronic devices on healthcare utilization: a meta-analysis of randomized controlled trials in
       patients with heart failure. Eur J Heart Fail 2016; 18: 195-204. PMID: 26817628
412. Böhm M, Drexler H, Oswald H, et al. OptiLink HF Study Investigators. Fluid status telemedicine alerts for heart failure: a randomized
       controlled trial. Eur Heart J 2016; 37: 3154-3163. PMID: 26984864
413. Yu CM, Wang L, Chau E, et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility
       of early warning preceding hospitalization. Circulation 2005; 112: 841-848. PMID: 16061743
414. Conraads VM, Tavazzi L, Santini M, et al. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring
       as a predictor of heart failure hospitalizations: the SENSE-HF trial. Eur Heart J 2011; 32: 2266-2273. PMID: 21362703
415. van Veldhuisen DJ, Braunschweig F, Conraads V, et al. DOT-HF Investigators. Intrathoracic impedance monitoring, audible patient
       alerts, and outcome in patients with heart failure. Circulation 2011; 124: 1719-1726. PMID: 21931078
416. Whellan DJ, Ousdigian KT, Al-Khatib SM, et al. PARTNERS Study Investigators. Combined heart failure device diagnostics identify
       patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending
       Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. J Am Coll Cardiol 2010; 55: 1803-1810. PMID:
       20413029
417. Bradley TD, Holloway RM, McLaughlin PR, et al. Cardiac output response to continuous positive airway pressure in congestive heart
       failure. Am Rev Respir Dis 1992; 145: 377-382. PMID: 1736745
418. Sin DD, Logan AG, Fitzgerald FS, et al. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients
       with and without Cheyne-Stokes respiration. Circulation 2000; 102: 61-66. PMID: 10880416
419. Yamada S, Sakakibara M, Yokota T, et al. Acute hemodynamic effects of adaptive servo-ventilation in patients with heart failure. Circ J
       2013; 77: 1214-1220. PMID: 23363644
420. Yoshida M, Kadokami T, Momii H, et al. Enhancement of cardiac performance by bilevel positive airway pressure ventilation in heart
       failure. J Card Fail 2012; 18: 912-918. PMID: 23207079
421. Ushijima R, Joho S, Akabane T, et al. Differing effects of adaptive servoventilation and continuous positive airway pressure on muscle
       sympathetic nerve activity in patients with heart failure. Circ J 2014; 78: 1387-1395. PMID: 24705391
422. Koyama T, Watanabe H, Igarashi G, et al. Short-term prognosis of adaptive servo-ventilation therapy in patients with heart failure. Circ
       J 2011; 75: 710-712. PMID: 21266785
423. Takama N, Kurabayashi M. Effect of adaptive servo-ventilation on 1-year prognosis in heart failure patients. Circ J 2012; 76: 661-667.
       PMID: 22199136
424. Momomura S, Seino Y, Kihara Y, et al. SAVIOR-C investigators. Adaptive servo-ventilation therapy for patients with chronic heart
       failure in a confirmatory, multicenter, randomized, controlled study. Circ J 2015; 79: 981-990. PMID: 25912560
425. Imamura T, Kinugawa K, Nitta D, et al. Long-Term Adaptive Servo- Ventilator Treatment Prevents Cardiac Death and Improves Clinical
       Outcome. Int Heart J 2016; 57: 47-52. PMID: 26742883
426. 日本循環器学会,日本心不全学会.心不全におけるASV の適正使用に関するステートメント(第2報).
       http://www.j-circ.or.jp/information/ASV_tekiseiriyou_rep2.pdf
427. Cowie MR, Woehrle H, Wegscheider K, et al. Adaptive Servo-Venti lation for Central Sleep Apnea in Systolic Heart Failure. N Engl J
       Med 2015; 373: 1095-1105. PMID: 26323938
428. Belardinelli R, Georgiou D, Cianci G, et al. Randomized, controlled trial of long-term moderate exercise training in chronic heart failure:
       effects on functional capacity, quality of life, and clinical outcome. Circulation 1999; 99: 1173-1182. PMID: 10069785
429. Stolen KQ, Kemppainen J, Ukkonen H, et al. Exercise training improves biventricular oxidative metabolism and left ventricular efficiency
       in patients with dilated cardiomyopathy. J Am Coll Cardiol 2003; 41: 460-467. PMID: 12575976
430. Coats AJ, Adamopoulos S, Radaelli A, et al. Controlled trial of physical training in chronic heart failure. Exercise performance,
       hemodynamics, ventilation, and autonomic function. Circulation 1992; 85:2119-2131. PMID: 1591831
431. Piña IL, Apstein CS, Balady GJ, et al. Exercise and heart failure: A statement from the American Heart Association Committee on
       exercise, rehabilitation, and prevention. Circulation 2003; 107: 1210-1225. PMID: 12615804
432. Jetté M, Heller R, Landry F, et al. Randomized 4-week exercise program in patients with impaired left ventricular function. Circulation
       1991; 84: 1561-1567. PMID: 1914097
433. Adamopoulos S, Coats AJ, Brunotte F, et al. Physical training improves skeletal muscle metabolism in patients with chronic heart failure.
       J Am Coll Cardiol 1993; 21: 1101-1106. PMID: 8459063
434. Hambrecht R, Niebauer J, Fiehn E, et al. Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness
       and ultrastructural abnormalities of leg muscles. J Am Coll Cardiol 1995; 25: 1239-1249. PMID: 7722116
435. Belardinelli R, Georgiou D, Scocco V, et al. Low intensity exercise training in patients with chronic heart failure. J Am Coll Cardiol
       1995; 26: 975-982. PMID: 7560627
436. Belardinelli R, Georgiou D, Cianci G, et al. Exercise training improves left ventricular diastolic filling in patients with dilated cardiomyopathy.
       Clinical and prognostic implications. Circulation 1995; 91: 2775-2784. PMID: 7758184
437. Kavanagh T, Myers MG, Baigrie RS, et al. Quality of life and cardiorespiratory function in chronic heart failure: effects of 12 months’
       aerobic training. Heart 1996; 76: 42-49. PMID: 8774326
438. Demopoulos L, Bijou R, Fergus I, et al. Exercise training in patients with severe congestive heart failure: enhancing peak aerobic capacity
       while minimizing the increase in ventricular wall stress. J Am Coll Cardiol 1997; 29: 597-603. PMID: 9060899
439. 安村良男,高木洋,原泰志,他.β遮断薬服用中の慢性心不全患者に対する低レベル運動療法の試み.心臓リハビリテーション
       1998; 3: 72-75.
440. Demopoulos L, Yeh M, Gentilucci M, et al. Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise
       training in patients with congestive heart failure. Circulation 1997; 95: 1764-1767. PMID: 9107160
441. Sullivan MJ, Higginbotham MB, Cobb FR. Exercise training in patients with severe left ventricular dysfunction. Hemodynamic and
       metabolic effects. Circulation 1988; 78: 506-515. PMID: 3409495
442. Kruse M, Hochstrasser S, Zwisler AD, et al. Comprehensive cardiac rehabilitation: a cost assessment based on a randomized clinical trial.
       Int J Technol Assess Health Care 2006; 22: 478-483. PMID: 16984681
443. Haykowsky MJ, Liang Y, Pechter D, et al. A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure
       patients: the benefit depends on the type of training performed. J Am Coll Cardiol 2007; 49: 2329-2336. PMID: 17572248
444. Giannuzzi P, Temporelli PL, Corrà U, et al. ELVD-CHF Study Group.Antiremodeling effect of long-term exercise training in patients with
       stable chronic heart failure: results of the Exercise in Left Ventricular Dysfunction and Chronic Heart Failure (ELVD-CHF) Trial. Circulation
       2003; 108: 554-559. PMID: 12860904
445. Myers J, Wagner D, Schertler T, et al. Effects of exercise training on left ventricular volumes and function in patients with nonischemic
       cardiomyopathy: application of magnetic resonance myocardial tagging. Am Heart J 2002; 144: 719-725. PMID: 12360170
446. Passino C, Severino S, Poletti R, et al. Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in
       patients with heart failure. J Am Coll Cardiol 2006; 47: 1835-1839. PMID: 16682309
447. Maria Sarullo F, Gristina T, Brusca I, et al. Effect of physical training on exercise capacity, gas exchange and N-terminal pro-brain
       natriuretic peptide levels in patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil 2006; 13: 812-817. PMID: 17001223
448. Ohtsubo M, Yonezawa K, Nishijima H, et al. Metabolic abnormality of calf skeletal muscle is improved by localised muscle training without
       changes in blood flow in chronic heart failure. Heart 1997; 78: 437-443. PMID: 9415000
449. Mancini DM, Henson D, La Manca J, et al. Benefit of selective respiratory muscle training on exercise capacity in patients with chronic
       congestive heart failure. Circulation 1995; 91: 320-329. PMID: 7805234
450. Chua TP, Anker SD, Harrington D, et al. Inspiratory muscle strength is a determinant of maximum oxygen consumption in chronic heart
       failure. Br Heart J 1995; 74: 381-385. PMID: 7488451
451. Kobayashi N, Tsuruya Y, Iwasawa T, et al. Exercise training in patients with chronic heart failure improves endothelial function
       predominantly in the trained extremities. Circ J 2003; 67: 505-510.PMID: 12808267
452. Hambrecht R, Fiehn E, Weigl C, et al. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in
       patients with chronic heart failure. Circulation 1998; 98: 2709-2715. PMID: 9851957
453. Kasapis C, Thompson PD. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J
       Am Coll Cardiol 2005; 45: 1563-1569. PMID: 15893167
454. Adamopoulos S, Parissis J, Karatzas D, et al. Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas
       ligand system in patients with chronic heart failure. J Am Coll Cardiol 2002; 39: 653-663. PMID: 11849865
455. Oya M, Itoh H, Kato K, et al. Effects of exercise training on the recovery of the autonomic nervous system and exercise capacity after
       acute myocardial infarction. Jpn Circ J 1999; 63: 843-848. PMID:10598888
456. Dimopoulos S, Anastasiou-Nana M, Sakellariou D, et al. Effects of exercise rehabilitation program on heart rate recovery in patients with
       chronic heart failure. Eur J Cardiovasc Prev Rehabil 2006; 13: 67-73. PMID: 16449866
457. Adamopoulos S, Ponikowski P, Cerquetani E, et al. Circadian pattern of heart rate variability in chronic heart failure patients. Effects of
       physical training. Eur Heart J 1995; 16: 1380-1386. PMID: 8746907
458. Piepoli MF, Davos C, Francis DP, et al. ExTraMATCH Collaborative.Exercise training meta-analysis of trials in patients with chronic heart
       failure (ExTraMATCH). BMJ 2004; 328: 189-189. PMID: 14729656
459. O’Connor CM, Whellan DJ, Lee KL, et al. HF-ACTION Investigators. fficacy and safety of exercise training in patients with chronic
       heart failure: HF-ACTION randomized controlled trial. JAMA 2009; 01: 1439-1450. PMID: 19351941
460. Sagar VA, Davies EJ, Briscoe S, et al. Exercise-based rehabilitationf or heart failure: systematic review and meta-analysis. Open Heart
       2015; 2: e000163. PMID: 25685361
461. Edelmann F, Gelbrich G, Düngen HD, et al. Exercise training improves exercise capacity and diastolic function in patients with heart
       failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study. J Am Coll Cardiol
       2011; 58: 1780-1791. PMID: 21996391
462. Nolte K, Herrmann-Lingen C, Wachter R, et al. Effects of exercise training on different quality of life dimensions in heart failure with
       preserved ejection fraction: the Ex-DHF-P trial. Eur J Prev Cardiol 2015; 22: 582-593. PMID: 24627449
463. Kitzman DW, Brubaker PH, Herrington DM, et al. Effect of endurance exercise training on endothelial function and arterial stiffness in
       older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial. J Am Coll Cardiol 2013;
       62: 584-592. PMID: 23665370
464. Pandey A, Parashar A, Kumbhani D, et al. Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis
       of randomized control trials. Circ Heart Fail 2015; 8: 33-40. PMID: 25399909
465. Belardinelli R, Capestro F, Misiani A, et al. Moderate exercise training improves functional capacity, quality of life, and endothelium-
       dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
       Eur J Cardiovasc Prev Rehabil 2006; 13: 818-825. PMID: 17001224
466. Patwala AY, Woods PR, Sharp L, et al. Maximizing patient benefit from cardiac resynchronization therapy with the addition of structured
       exercise training: a randomized controlled study. J Am Coll Cardiol 2009; 53: 2332-2339. PMID: 19539142
467. Mereles D, Ehlken N, Kreuscher S, et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with
       severe chronic pulmonary hypertension. Circulation 2006; 114: 1482- 1489. PMID: 16982941
468. Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint
       Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European
       Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society
       for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016; 37: 67-119. PMID: 26320113
469. Conraads VM, Beckers P, Vaes J, et al. Combined endurance/resistance training reduces NT-proBNP levels in patients with chronic
       heart failure. Eur Heart J 2004; 25: 1797-1805. PMID: 15474694
470. Beckers PJ, Denollet J, Possemiers NM, et al. Combined endurance- resistance training vs. endurance training in patients with chronic
       heart failure: a prospective randomized study. Eur Heart J 2008; 29: 1858-1866. PMID: 18515805
471. Feiereisen P, Delagardelle C, Vaillant M, et al. Is strength training the more efficient training modality in chronic heart failure? Med Sci
       Sports Exerc 2007; 39: 1910-1917. PMID: 17986897
472. Jewiss D, Ostman C, Smart NA. The effect of resistance training on clinical outcomes in heart failure: A systematic review and meta-
       analysis. Int J Cardiol 2016; 221: 674-681. PMID: 27423089
473. Vigorito C, Abreu A, Ambrosetti M, et al. Frailty and cardiac rehabilitation: A call to action from the EAPC Cardiac Rehabilitation Section.
       Eur J Prev Cardiol 2017; 24: 577-590. PMID: 27940954
474. Wisløff U, Støylen A, Loennechen JP, et al. Superior cardiovascular effect of aerobic interval training versus moderate continuous training
       in heart failure patients: a randomized study. Circulation 2007; 115: 3086-3094. PMID: 17548726
475. Haykowsky MJ, Timmons MP, Kruger C, et al. Meta-analysis of aerobic interval training on exercise capacity and systolic function in
       patients with heart failure and reduced ejection fractions. Am J Cardiol 2013; 111: 1466-1469. PMID: 23433767
476. Guiraud T, Nigam A, Gremeaux V, et al. High-intensity interval training in cardiac rehabilitation. Sports Med 2012; 42: 587-605. PMID:
       22694349
477. Cornish AK, Broadbent S, Cheema BS. Interval training for patients with coronary artery disease: a systematic review. Eur J Appl Physiol
       2011; 111: 579-589. PMID: 20972578
478. Ellingsen Ø, Halle M, Conraads V, et al. SMARTEX Heart Failure Study (Study of Myocardial Recovery After Exercise Training in
       Heart Failure) Group. High-Intensity Interval Training in Patients With Heart Failure With Reduced Ejection Fraction. Circulation
       2017; 135: 839-849. PMID: 28082387
479. Schnabel RB, Sullivan LM, Levy D, et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-
       based cohort study. Lancet 2009; 373: 739-745. PMID: 19249635
480. Yamauchi T, Sakata Y, Miura M, et al. CHART-2 Investigators. Prognostic Impact of Atrial Fibrillation and New Risk Score of Its Onset
       in Patients at High Risk of Heart Failure - A Report From the CHART-2 Study. Circ J 2017; 81: 185-194. PMID: 28090009
481. Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National
       Registry of Atrial Fibrillation. JAMA 2001; 285: 2864-2870. PMID: 11401607
482. Prystowsky EN, Benson DW, Fuster V, et al. Management of patients with atrial fibrillation. A Statement for Healthcare Professionals.
       From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation 1996; 93: 1262-1277.
       PMID: 8653857
483. Hart RG, Halperin JL. Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention. Ann Intern Med 1999; 131:
       688-695. PMID: 10577332
484. Mancini GB, Goldberger AL. Cardioversion of atrial fibrillation: consideration of embolization, anticoagulation, prophylactic pacemaker,
       and long-term success. Am Heart J 1982; 104: 617-621. PMID: 7113903
485. Fresco C, Proclemer A. Clinical challenge. II. Management of recent onset atrial fibrillation. PAFIT-2 Investigators. Eur Heart J 1996; 17
       Suppl C: 41-47. PMID: 8809538
486. Nagai R, Kinugawa K, Inoue H, et al. J-Land Investigators. Urgent management of rapid heart rate in patients with atrial fibrillation/flutter
       and left ventricular dysfunction: comparison of the ultra-short-acting β1-selective blocker landiolol with digoxin (J-Land Study). Circ
       J 2013; 77: 908-916. PMID: 23502991
487. Horiuchi D, Sasaki S, Kinjo T, et al. Rhythm and rate control effects of intravenous amiodarone for atrial fibrillation complicated by acutely
       decompensated heart failure. J Arrhythm 2014; 30: 167-172.
488. Li SJ, Sartipy U, Lund LH, et al. Prognostic Significance of Resting Heart Rate and Use of β-Blockers in Atrial Fibrillation and Sinus
       Rhythm in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Swedish Heart Failure Registry. Circ Heart
       Fail 2015; 8: 871-879. PMID: 26243796
489. Rawles JM. What is meant by a “controlled” ventricular rate in atrial fibrillation? Br Heart J 1990; 63: 157-161. PMID: 2183858
490. 日本循環器学会.心房細動治療(薬物)ガイドライン(2013年改訂版).http://www.j-circ.or.jp/guideline/pdf/JCS2013_inoue_h.pdf
491. Roy D, Talajic M, Nattel S, et al. Atrial Fibrillation and Congestive Heart Failure Investigators. Rhythm control versus rate control for
       atrial fibrillation and heart failure. N Engl J Med 2008; 358: 2667- 2677. PMID: 18565859
492. Khand AU, Rankin AC, Martin W, et al. Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients
       with heart failure? J Am Coll Cardiol 2003; 42: 1944-1951. PMID: 14662257
493. Fauchier L, Grimard C, Pierre B, et al. Comparison of beta blocker and digoxin alone and in combination for management of patients
       with atrial fibrillation and heart failure. Am J Cardiol 2009; 103: 248- 254. PMID: 19121446
494. Shiga T, Wakaumi M, Imai T, et al. Effect of low-dose amiodarone on atrial fibrillation or flutter in Japanese patients with heart failure. Circ
       J 2002; 66: 600-604. PMID: 12074281
495. Nakazato Y. The Resurfacing of Bepridil Hydrochloride on the World Stage as an Antiarrhythmic Drug for Atrial Fibrillation. J Arrhythm
       2009; 25: 4-9.
496. Hayashi M, Tanaka K, Kato T, et al. Enhancing electrical cardioversion and preventing immediate reinitiation of hemodynamically
       deleterious atrial fibrillation with class III drug pretreatment. J Cardiovasc Electrophysiol 2005; 16: 740-747. PMID: 16050832
497. Flaker GC, Blackshear JL, McBride R, et al. Stroke Prevention in Atrial Fibrillation Investigators. Antiarrhythmic drug therapy and cardiac
       mortality in atrial fibrillation. J Am Coll Cardiol 1992; 20: 527- 532. PMID: 1512329
498. Haïssaguerre M, Jaïs P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N
       Engl J Med 1998; 339: 659-666. PMID: 9725923
499. 日本循環器学会.循環器病の診断と治療に関するガイドライン2012.カテーテルアブレーションの適応と手技に関するガイドライン.
       http://www.j-circ.or.jp/guideline/pdf/JCS2012_okumura_h.pdf
500. Inoue K, Murakawa Y, Nogami A, et al. Japanese Heart Rhythm Society Members. Current status of catheter ablation for atrial fibrillation--
       updated summary of the Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF). Circ J 2014; 78: 1112-1120. PMID:
       24632790
急性・慢性心不全診療ガイドライン(2017年改訂版)
Guidelines for Diagnosis and Treatment of Acute and Chronic Heart Failure
(JCS 2017/JHFS 2017)
次へ